US HB6897 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on December 22 2023 - 25% progression
Action: 2023-12-22 - Referred to the House Committee on Armed Services.
Pending: House Armed Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 22 2023 - 25% progression
Action: 2023-12-22 - Referred to the House Committee on Armed Services.
Pending: House Armed Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.
Title
Synthetic Biology and Active Pharmaceutical Ingredients Act
Sponsors
| Rep. Elissa Slotkin [D-MI] | Rep. Mike Gallagher [R-WI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-12-22 | House | Referred to the House Committee on Armed Services. |
| 2023-12-22 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/6897/all-info |
| Text | https://www.congress.gov/118/bills/hr6897/BILLS-118hr6897ih.pdf |
